LAXMIDENTL share price & delivery %

Filings & corporate actions

7 results filed

CSV

Next results · Q2 FY27

Expected 10 Nov 2026 – 18 Dec 2026

Estimate: filed 41–79 days after quarter end, last 7 times

2026

11 AugresultsResults · Q1 FY27 · consolidated and standalone-5.0%NSE
20 JulshareholdingShareholding · 30 Jun 2026+1.2%NSE
21 MayresultsResults · Q4 FY26 · consolidated and standalone+20.0%NSE
20 AprshareholdingShareholding · 31 Mar 2026-0.8%NSE
10 FebresultsResults · Q3 FY26 · consolidated and standalone-9.2%NSE
13 JanshareholdingShareholding · 31 Dec 2025-0.2%NSE

Reaction to results · all yearsrose on day 0 in 3 of 7 CSV

Quarter	Filed	Day 0	+5D	+20D	Rel vol
Q1 FY27	11 Aug 2026	-5.0%	-7.1%	-4.6%	4.1×
Q4 FY26	21 May 2026	+20.0%	+10.9%	+8.5%	17.0×
Q3 FY26	10 Feb 2026	-9.2%	-17.4%	-19.0%	2.1×
Q2 FY26	18 Dec 2025	+0.5%	+1.3%	-11.5%	0.1×
Q1 FY26	12 Aug 2025	-3.5%	-11.2%	-22.2%	1.5×
Q4 FY25	28 May 2025	+0.1%	+7.0%	+17.1%	1.5×
Q3 FY25	14 Feb 2025	-2.9%	-8.9%	+12.8%	0.6×
Average		-0.0%	-3.6%	-2.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV

Revenue YoY+13.9%

Profit YoY+23.8%

Interest cost YoY—

Revenue QoQ+1.0%

Profit QoQ+2.2%

CAGR	2Y	3Y	4Y	5Y	6Y	7Y
Revenue	—	—	—	—	—	—
Profit	—	—	—	—	—	—

Key data

CSV

Open190.54

Day range188.21 – 192.38

52-week range155.88 – 344.80

From 52w high-44.7%

RSI (14)39.3

ATR (14)6.16

Volume34.9K

Avg volume (20D)61.4K

Rel volume0.57×

Volatility (1Y)47.3%

Turnover₹66.4L

SMA 50 / 200201.50 / 210.55

Delivery percentage

Latest · 6 Oct 202659.3%

20-day avg53.4%

1-year avg44.7%

Percentile (own history)91st

Range5.4–87.8%

Sessions424

Over the last 20 sessions LAXMIDENTL settled 53.4% of its traded quantity, which is above average for an NSE equity. Its one-year average is 44.7%, so recent sessions are running 8.7 points higher than usual. The latest session ranks higher than 91% of the 424 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

IndustryMedical Equipment & Supplies

PeersMOLBIO POLYMED TARSONS FISCHER FABTECH GKB

Performance returns

CSV

	1D	1W	1M	3M	6M	1Y
Price	-0.01%	-1.13%	-4.35%	-14.19%	+5.67%	-39.88%

Valuation

CSV

Market cap₹1,048 Cr

P/E (TTM)33.9

EPS (TTM)5.62

Shares outstanding5.50Cr

Listed20 Jan 2025

Ownership

CSV

Promoter41.80%

Promoter Δ QoQ+0.03 pp

Public58.20%

FII30.10%

DII10.89%

Pledged0.00%

Quarterly results · consolidated

CSV

	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue (₹ Cr)	72.3	66.0	74.0	74.7
YoY chg	—	+7.1%	+21.9%	+13.9%
Net profit (₹ Cr)	8.5	2.0	10.1	10.3
YoY chg	—	-59.3%	+136.1%	+23.8%
Net margin	11.8%	3.0%	13.7%	13.8%
EPS	1.58	0.36	1.83	1.87

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 41.80% · public 58.20%

2025-012026-06

Promoter
Public and others

Promoter: 41.80%
Public: 58.20%
Promoter change: +0.03 pp
Filed: 20 Jul 2026

FII: 30.10%
DII: 10.89%
Promoter pledged: 0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV

₹ crore, as filed

	Q3 FY25	Q4 FY25^A	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26^A	Q1 FY27
Revenue from operations	61.7	60.7	65.6	72.3	66.0	74.0	74.7
Other income	0.6	1.6	1.7	2.4	2.1	2.4	2.3
Total income	62.2	62.3	67.3	74.7	68.1	76.3	77.0
Total expenses	57.5	56.7	57.7	65.2	63.6	65.2	65.0
└ Finance costs	1.5	1.3	0.5	0.2	0.3	0.3	0.3
└ Depreciation	4.0	4.3	3.6	3.7	4.2	4.4	4.3
Profit before tax	4.7	6.0	9.6	9.4	(1.2)	11.1	12.0
Tax expense	1.1	2.5	2.3	1.9	(2.2)	0.5	2.5
Net profit	4.8	4.3	8.3	8.5	2.0	10.1	10.3
EPS	0.88	0.79	1.53	1.59	0.37	1.83	1.87
Net margin	7.81%	7.05%	12.70%	11.81%	2.97%	13.65%	13.81%
PBT margin	7.64%	9.91%	14.63%	13.04%	-1.86%	15.06%	16.12%
Tax rate	22.71%	41.23%	23.84%	19.79%	—	4.49%	20.71%

^A audited · ^R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 11 Aug 2026.

LAXMIDENTL at a glance

LAXMIDENTL closed at ₹190.53 on 6 Oct 2026, -0.01% on the day, -39.9% over one year, 44.7% below its 52-week high of ₹344.8.
Delivery was 59.3% of traded quantity on 6 Oct 2026, the 91st percentile of its own 424 sessions with a reading (20-session average 53.4%, 1-year average 44.7%).
Market capitalisation is ₹1,048 crore at a trailing P/E of 33.9 (trailing EPS ₹5.62).
Q1 FY27 results (consolidated, filed 11 Aug 2026): revenue ₹75 crore (+13.9% year on year), net profit ₹10 crore (+23.8%); the price moved -5.0% on the first session after.
Promoters held 41.80% at 30 Jun 2026, up 0.03 percentage points on the previous filing.
Q2 FY27 results are expected between 10 Nov 2026 and 18 Dec 2026, going by past filing dates — an estimate, not an announcement.

About

CSV

Macro sectorHealthcare

Basic industryMedical Equipment & Supplies

ISININE0WO601020

SeriesEQ

Listed20 Jan 2025

History from20 Jan 2025

Sessions424

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Equipment & Supplies

CSV

All Healthcare Equipment & Supplies stocks on the NSE All Healthcare stocks on the NSE